• LAST PRICE
    24.0000
  • TODAY'S CHANGE (%)
    Trending Up1.5300 (6.8091%)
  • Bid / Lots
    23.9500/ 1
  • Ask / Lots
    24.0000/ 2
  • Open / Previous Close
    24.0100 / 22.4700
  • Day Range
    Low 22.9300
    High 24.0100
  • 52 Week Range
    Low 13.8200
    High 25.9500
  • Volume
    262,432
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 22.47
TimeVolumeMYGN
09:32 ET3328023.84
09:34 ET200023.44
09:36 ET50023.37
09:38 ET62223.37
09:39 ET120023.3
09:41 ET291023.3125
09:43 ET60023.285
09:45 ET42423.28
09:48 ET106223.39
09:50 ET427223.59
09:52 ET79623.48
09:54 ET220023.495
09:56 ET83723.55
09:57 ET162523.49
09:59 ET60023.53
10:01 ET469323.65
10:03 ET122723.51
10:06 ET175023.42
10:08 ET46723.435
10:10 ET30023.425
10:12 ET160823.52
10:14 ET132723.545
10:15 ET48823.59
10:17 ET60023.545
10:19 ET55523.6
10:21 ET96523.54
10:24 ET50023.615
10:26 ET160123.58
10:28 ET60023.62
10:30 ET71323.57
10:32 ET166323.58
10:33 ET110223.65
10:35 ET20023.61
10:39 ET80023.66
10:42 ET30023.58
10:44 ET30023.485
10:46 ET70023.48
10:48 ET402323.54
10:50 ET60023.59
10:51 ET95223.525
10:53 ET92723.57
10:55 ET147723.62
10:57 ET60023.66
11:00 ET20023.68
11:02 ET72023.665
11:06 ET280723.655
11:08 ET60023.69
11:09 ET30023.71
11:11 ET40823.6906
11:13 ET70023.66
11:15 ET76723.63
11:18 ET30023.66
11:20 ET20023.65
11:22 ET50023.635
11:26 ET50023.55
11:27 ET134523.5995
11:29 ET30023.59
11:36 ET125323.555
11:38 ET180223.58
11:42 ET20023.6
11:44 ET60023.64
11:45 ET31223.64
11:47 ET40023.6186
11:51 ET49823.635
11:54 ET50023.67
11:56 ET20023.67
11:58 ET60023.69
12:00 ET20023.67
12:02 ET93523.68
12:03 ET211023.69
12:05 ET10023.695
12:07 ET40023.74
12:09 ET10023.71
12:12 ET50023.615
12:14 ET20023.65
12:16 ET20023.595
12:18 ET20023.595
12:20 ET226723.59
12:21 ET265923.56
12:23 ET60023.575
12:25 ET207423.61
12:30 ET82723.64
12:34 ET20023.66
12:36 ET60023.68
12:38 ET272623.71
12:39 ET20023.7
12:41 ET10023.7
12:43 ET70723.7
12:45 ET84123.725
12:50 ET47623.71
12:52 ET38823.715
12:54 ET10023.73
12:56 ET3053223.78
12:57 ET518123.87
12:59 ET59023.87
01:01 ET176423.85
01:03 ET110023.89
01:06 ET1088923.89
01:08 ET135123.93
01:10 ET150423.98
01:12 ET41724
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMYGN
Myriad Genetics Inc
2.0B
-8.5x
---
United StatesWRBY
Warby Parker Inc
2.0B
-36.4x
---
United StatesUFPT
UFP Technologies Inc
1.9B
41.2x
+24.81%
United StatesNVCR
Novocure Ltd
2.3B
-11.8x
---
United StatesSTAA
STAAR Surgical Co
1.9B
134.6x
+31.52%
United StatesPINC
Premier Inc
2.0B
29.1x
-12.96%
As of 2024-06-12

Company Information

Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, EndoPredict, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight.

Contact Information

Headquarters
322 North 2200 WestSALT LAKE CITY, UT, United States 84116
Phone
801-584-3600
Fax
801-584-3640

Executives

Independent Chairman of the Board
S. Louise Phanstiel
President, Chief Executive Officer, Director
Paul Diaz
Chief Financial Officer
Scott Leffler
President, Chief Clinical Officer - Oncology
George Daneker
Chief Operating Officer
Sam Raha

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.0B
Revenue (TTM)
$774.2M
Shares Outstanding
90.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.96
EPS
$-2.82
Book Value
$8.71
P/E Ratio
-8.5x
Price/Sales (TTM)
2.6
Price/Cash Flow (TTM)
---
Operating Margin
-30.11%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.